Phase I Trial of 177Lutetium-Labeled J591, a Monoclonal Antibody to Prostate-Specific Membrane Antigen, in Patients With Androgen-Independent Prostate Cancer

Patrick C. Walsh

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Phase I Trial of 177Lutetium-Labeled J591, a Monoclonal Antibody to Prostate-Specific Membrane Antigen, in Patients With Androgen-Independent Prostate Cancer'. Together they form a unique fingerprint.